Learn More
tive pathway that results in the engulfment and degradation of cytoplasmic contents in response to nutrient starvation or metabolic stress. A study by Tang et al. pro­ vides evidence that high(More)
drugs is their inability to target and penetrate tumour tissue, leading to reduced efficacy and nonspecific adverse effects on normal cells. In a study published in Science, researchers led by Erkki(More)
recurrent prostate cancer (CRPC) is generally believed to involve the androgen receptor (AR) in most patients. Current treatments target the AR ligand-binding domain (LBD) but these all eventually(More)